Shooting for the stars here on Earth

I was grateful for the linkurl:invitation;http://www.amnh.org/rose/specials/?src=p_h to witness the return to Earth of NASA?s Stardust mission broadcast live from the American Museum of Natural History this Sunday. While the notion of roaming the halls of a favorite childhood retreat at 5am is appealing, I?m even more enthralled by the possibilities of Stardust, an unmanned spacecraft which captured particles from the comet Wild 2 offering the possibility of a glimpse into the very birth of the

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
I was grateful for the linkurl:invitation;http://www.amnh.org/rose/specials/?src=p_h to witness the return to Earth of NASA?s Stardust mission broadcast live from the American Museum of Natural History this Sunday. While the notion of roaming the halls of a favorite childhood retreat at 5am is appealing, I?m even more enthralled by the possibilities of Stardust, an unmanned spacecraft which captured particles from the comet Wild 2 offering the possibility of a glimpse into the very birth of the solar system. I?m no space addict, although I will admit a certain level of giddiness any time I get to talk to a real astronaut. Jay Buckey who linkurl:wrote for us;http://www.the-scientist.com/article/display/15336/ on potential hurdles in a manned mission to Mars was no exception. Nevertheless, while I agree we have the potential to send people to Mars and that the quest to do so would result in some interesting technological advancements, I doubt that the discoveries could trump the enormous amounts of information derived from recent unmanned missions. Dollars-to-discoveries, you can?t beat the value of unmanned missions. Spirit and Discovery are still sending back information from Mars long after their mission?s expiration date, and the cost was several orders of magnitude less than a manned mission. Nevertheless, Bush is bent on sending people to mars by 2015. The sting of this push was realized with the release of the federal appropriations budget for R&D in fiscal year 2006. AAAS linkurl:reviews the numbers here;http://www.aaas.org/spp/rd/upd1205.htm. Of the $2.2 billion dollar increase from last year, 97% of funds are going to defense-weapons development and human space flight. This seems a bit short sighted as we?re on the cusp of so many exciting life science discoveries here on Earth and hundreds of millions of dollars (not to mention a few human lives) could be better protected by sending robots out into the great beyond. The move has some grumbling that George W. Bush?s record doubling of the NIH budget may have meant more trouble for life science spending in the long run than it did in the short run.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies